Cargando...
Chemoresistance in ovarian cancer: exploiting cancer stem cell metabolism
Ovarian cancer is most deadly gynecologic malignancies worldwide. Chemotherapy is the mainstay treatment for ovarian cancer. Despite the initial response is promising, frequent recurrence in patients with advanced diseases remains a therapeutic challenge. Thus, understanding the biology of chemoresi...
Gardado en:
| Publicado en: | J Gynecol Oncol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5823988/ https://ncbi.nlm.nih.gov/pubmed/29468856 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3802/jgo.2018.29.e32 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|